Skip to main content
Livermore
Livermore
ZHEN

Longboard Pharmaceuticals, Inc.

LBPHDelisted Dec 2, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001832168

Longboard Pharmaceuticals, Inc. was delisted on Dec 2, 2024; its insiders filed their last Form 4 on Dec 2, 2024; 125 institutions reported holding it in 13F filings for Q3 2024, worth $1.33B in total; Viking Global Investors was the only superinvestor holding it.

Q3 2024 vs. Q2 2024

How the institutions holding Longboard Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of LBPH: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders1001125+26
Shares38.8M2.37M39.8M+3.37M (+9.3%)
Value$1.05B$64.0M$1.33B+$341.9M (+34.7%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (36)

Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to LBPH in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.2,837,880$94.6M0.00%
Siren, L.L.C.903,227$30.1M1.51%
Soleus Capital Management, L.P.318,269$10.6M0.88%
Braun Stacey Associates Inc299,156$9.97M0.38%
OrbiMed Advisors LLC170,000$5.67M0.10%
PFM Health Sciences, LP113,711$3.79M0.22%
Readystate Asset Management LP107,345$3.58M0.19%
Decheng Capital LLC56,350$1.88M0.44%
Trexquant Investment LP25,305$843.4K0.01%
Tudor Investment Corp Et Al18,925$630.8K0.01%
SEI Investments Co16,631$554.3K0.00%
Victory Capital Management Inc15,773$525.7K0.00%
Qube Research & Technologies Ltd14,844$494.8K0.00%
Raymond James & Associates12,200$406.6K0.00%
Nebula Research & Development LLC11,446$381.5K0.05%
SG Americas Securities, LLC10,514$350.0K0.00%
Profund Advisors LLC9,772$325.7K0.01%
Rafferty Asset Management, LLC8,776$292.5K0.00%
Verition Fund Management LLC8,469$282.3K0.00%
Teacher Retirement System of Texas8,289$276.0K0.00%
Intech Investment Management LLC8,133$271.1K0.00%
D. E. Shaw & Co., Inc.6,800$226.6K0.00%
Mesirow Financial Investment Management, Inc.6,634$221.1K0.00%
Norges Bank6,600$220.0K0.00%
ProShare Advisors LLC6,111$203.7K0.00%
KBC Group NV1,954$65.0K0.00%
Public Employees Retirement Association of Colorado1,490$50.0K0.00%
Acadian Asset Management LLC1,274$42.0K0.00%
Federation des caisses Desjardins du Quebec550$18.3K0.00%
Jones Financial Companies LLLP500$16.0K0.00%
Smartleaf Asset Management LLC142$4.54K0.00%
Simplex Trading, LLC104$3.00K0.00%
Sterling Capital Management LLC33$1.10K0.00%
Bessemer Group Inc30$1.00K0.00%
Capital Advisors, Ltd. LLC9$00.00%
Covestor Ltd3$00.00%

Sold out (10)

Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of LBPH in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Ra Capital Management, L.P.3,289,119$88.9M
Point72 Asset Management, L.P.1,031,371$27.9M
Alyeska Investment Group, L.P.212,879$5.75M
Braidwell LP205,926$5.57M
Lynx1 Capital Management LP167,317$4.52M
ExodusPoint Capital Management, LP80,514$2.18M
Laurion Capital Management LP66,149$1.79M
Y-Intercept (Hong Kong) Ltd21,242$574.2K
Susquehanna International Group, LLP8,032$217.1K
Shay Capital LLC7,500$202.7K

Not filed for Q3 2024 yet (1)

Institutions that held Longboard Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding LBPH in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.2,368,451$64.0M